Reproducibility over time and effect of low-dose aspirin on soluble P-selectin and soluble CD40 ligand.

scientific article

Reproducibility over time and effect of low-dose aspirin on soluble P-selectin and soluble CD40 ligand. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S11239-015-1179-5
P932PMC publication ID5514372
P698PubMed publication ID25648873
P5875ResearchGate publication ID272076648

P50authorMichael A NardiQ56246776
P2093author name stringJeffrey S Berger
Vanessa Valdes
Lindsay Elbaum
P2860cites workMeasurement of soluble P-selectin and soluble CD40 ligand in serum and plasmaQ57313116
CD40-CD40L and platelet function: beyond hemostasisQ73400879
Pre-analytical variation in the measurements of sensitive markers of coagulation and fibrinolysis: the influence of venipuncture and mixing of bloodQ73718391
Platelet P-selectin facilitates atherosclerotic lesion developmentQ78654773
Influence of pre-analytical and analytical factors on soluble CD40L measurementsQ79952846
P-selectin mediates adhesion of leukocytes, platelets, and cancer cells in inflammation, thrombosis, and cancer growth and metastasisQ28237380
Differences of soluble CD40L in sera and plasma: implications on CD40L assay as a marker of thrombotic riskQ33362119
Platelet activity and cardiovascular risk in apparently healthy individuals: a review of the dataQ33896059
Pre-analytical and analytical variables affecting the measurement of plasma-derived microparticle tissue factor activity.Q35738647
CD40/CD40L system and vascular disease.Q37017170
Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis.Q37127450
Mean platelet volume reproducibility and association with platelet activity and anti-platelet therapy.Q37257153
The CD40/CD40 ligand system: linking inflammation with atherothrombosisQ37579360
Soluble CD40L and cardiovascular risk in womenQ40677583
Soluble P-selectin and the risk of future cardiovascular eventsQ40729226
Hypothesis: is soluble P-selectin a new marker of platelet activation?Q41364350
Increased plasma levels of soluble CD40 ligand correlate with platelet activation markers and underline the need for standardized pre-analytical conditionsQ43198801
Soluble P-selectin as a marker of in vivo platelet activationQ46331584
Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular diseaseQ46794553
P433issue1
P921main subjectaspirinQ18216
reproducibilityQ1425625
P304page(s)83-87
P577publication date2015-07-01
P1433published inJournal of Thrombosis and ThrombolysisQ15766541
P1476titleReproducibility over time and effect of low-dose aspirin on soluble P-selectin and soluble CD40 ligand
P478volume40

Reverse relations

cites work (P2860)
Q58577562Association between P-selectin levels and left atrial blood stasis in patients with nonvalvular atrial fibrillation
Q41096059Increased Soluble VCAM-1 and Normal P-Selectin in Cystic Fibrosis: a Cross-Sectional Study
Q37018644Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis
Q100523696Proteomic Profiling Identifies Key Differences Between Inter-Stage Infants with Single Ventricle Heart Disease and Healthy Controls
Q35735264Soluble CD40 Ligand in Aspirin-Treated Patients Undergoing Cardiac Catheterization
Q90723624The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
Q52725381The non-haemostatic role of platelets in systemic lupus erythematosus.